Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | HLA-DOA |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → HLA-DOA |
| (<<) BLNK → HLA-DOA |
| (<<) CCND2 → HLA-DOA |
| (<<) CORO1A → HLA-DOA |
| (<<) GYPC → HLA-DOA |
| (<<) INPP5D → HLA-DOA |
| (<<) KCTD12 → HLA-DOA |
| (<<) MYO1E → HLA-DOA |
| (<<) PRKACB → HLA-DOA |
| (<<) PTGER4 → HLA-DOA |
| (<<) SH3KBP1 → HLA-DOA |
| (<<) VAV1 → HLA-DOA |
| Downstream (Children) |
|---|
| HLA-DOA → ASB2 (>>) |
| HLA-DOA → CCDC88A (>>) |
| HLA-DOA → CSTA (>>) |
| HLA-DOA → DHRS9 (>>) |
| HLA-DOA → DOK7 (>>) |
| HLA-DOA → HDAC9 (>>) |
| HLA-DOA → HSPA5 (>>) |
| HLA-DOA → MAPK3 (>>) |
| HLA-DOA → MST1R (>>) |
| HLA-DOA → VEGFA (>>) |
